4//SEC Filing
Ruffner Katherine L 4
Accession 0001628280-21-013826
CIK 0001213037other
Filed
Jul 13, 8:00 PM ET
Accepted
Jul 14, 4:00 PM ET
Size
5.5 KB
Accession
0001628280-21-013826
Insider Transaction Report
Form 4
Ruffner Katherine L
Chief Medical Officer
Transactions
- Award
Stock Options
2021-07-12+200,000→ 200,000 totalExercise: $6.55Exp: 2031-07-12→ Common Stock (200,000 underlying)
Footnotes (1)
- [F1]25% vest on 7/12/2022. The remainder vest in equal installments monthly for 36 months beginning on 8/12/2022 through 7/12/2025.
Documents
Issuer
Cardiff Oncology, Inc.
CIK 0001213037
Entity typeother
Related Parties
1- filerCIK 0001872306
Filing Metadata
- Form type
- 4
- Filed
- Jul 13, 8:00 PM ET
- Accepted
- Jul 14, 4:00 PM ET
- Size
- 5.5 KB